Ultra-low exposure to alpha-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in alpha-7 receptor expression in rodents: implications for low dose clinical efficacy-Reference-Cited by-同舟云学术

Ultra-low exposure to alpha-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in alpha-7 receptor expression in rodents: implications for low dose clinical efficacy

Published:2011-07 Issue: Volume:186 Page:76-87
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Werkheiser J.L.,Sydserff S.,Hubbs S.J.,Ding M.,Eisman M.S.,Perry D.,Williams A.J.,Smith J.S.,Mrzljak L.,Maier D.L.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference44 articles.

1. alpha-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with alpha 7 subunits and up-regulation by chronic nicotine treatment;Barrantes;Brain Res,1995

2. Synaptic plasticity and the neurobiology of learning and memory;Benfenati;Acta Biol Med,2007

3. SSR180711, a novel selective α7 nicotinic receptor partial agonist: binding and functional profile;Biton;Neuropsychopharmacology,2007

4. Spatial memory, recognition memory, and the hippocampus;Broadbent;Proc Natl Acad Sci U S A,2004

5. Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptors;Castner;Biol Psychiatry,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of memantine and alpha7 nicotinic acetylcholine receptor ligands exerts superior efficacy over monotreatments to improve cognitive performance of aged rats;2023-09-23

2. CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study;Psychopharmacology;2020-08-27

3. Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia;International Journal of Psychophysiology;2019-11

4. Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury;PLOS ONE;2019-10-03

5. Combining CDP-choline and galantamine: Effects of a selective α7 nicotinic acetylcholine receptor agonist strategy on P50 sensory gating of speech sounds in healthy volunteers;Journal of Psychopharmacology;2019-03-28